Annual report pursuant to Section 13 and 15(d)

Sponsored Research and Clinical Trial Agreements (Tables)

v3.21.1
Sponsored Research and Clinical Trial Agreements (Tables)
12 Months Ended
Dec. 31, 2020
Aevitas [Member]  
Schedule of Research and Development for Sponsored Research and Clinical Trial Agreements

For the Year Ended December 31, 

($ in thousands)

    

2020

    

2019

UMass - adeno-associated virus ("AAV")

$

381

$

UPenn - AAV

567

1,067

Duke - AAV

66

Total

$

948

$

1,133

Mustang [Member]  
Schedule of Research and Development for Sponsored Research and Clinical Trial Agreements

For the years ended December 31, 2020 and 2019 Mustang recorded the following expense in research and development for sponsored research and clinical trial agreements:

For the Year Ended December 31, 

($ in thousands)

    

2020

    

2019

City of Hope National Medical Center

$

500

$

2,000

CD123 (MB-102)

 

433

 

1,202

IL13Rα2 (MB-101)

 

530

 

876

Manufacturing

 

 

457

CS1 (MB-104)

885

HER2 (MB-103)

1,519

PSCA (MB-105)

204

Beth Israel Deaconess Medical Center - CRISPR

69

St. Jude Children's Research Hospital - XSCID (MB-107)

1,842

777

Fred Hutchinson Cancer Research Center - CD20 (MB-106)

1,804

762

Total

$

7,717

$

6,143